Waters Corporation (WAT)

NYSE: WAT · IEX Real-Time Price · USD
332.15
-5.72 (-1.69%)
Aug 8, 2022 4:04 PM EDT - Market closed
-1.69%
Market Cap 20.01B
Revenue (ttm) 2.90B
Net Income (ttm) 702.12M
Shares Out 60.24M
EPS (ttm) 11.58
PE Ratio 28.68
Forward PE 28.57
Dividend n/a
Ex-Dividend Date n/a
Volume 305,584
Open 338.51
Previous Close 337.87
Day's Range 330.41 - 339.11
52-Week Range 288.32 - 428.22
Beta 0.82
Analysts Hold
Price Target 353.63 (+6.5%)
Earnings Date Aug 2, 2022

About WAT

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry inst... [Read more...]

Industry Life Sciences Tools & Services
IPO Date Nov 16, 1995
CEO Christopher O'Connell
Employees 7,800
Stock Exchange NYSE
Ticker Symbol WAT
Full Company Profile

Financial Performance

In 2021, Waters's revenue was $2.79 billion, an increase of 17.78% compared to the previous year's $2.37 billion. Earnings were $692.84 million, an increase of 32.84%.

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for WAT stock is "Hold." The 12-month stock price forecast is 353.63, which is an increase of 6.47% from the latest price.

Price Target
$353.63
(6.47% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Waters (WAT) Q2 Earnings & Sales Surpass Estimates, Rise Y/Y

Waters' (WAT) second-quarter results reflect gains from a strong momentum across pharmaceutical and industrial end-markets, and geographical regions.

Waters (WAT) Beats Q2 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of 4.56% and 1.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Waters Corporation (NYSE: WAT) Reports Second Quarter 2022 Financial Results

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced its financial results for the second quarter of 2022. “Our team's strong focus on execution continued to deliver excellent...

Waters (WAT) Earnings Expected to Grow: Should You Buy?

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins

MILFORD, Mass.--(BUSINESS WIRE)-- #alternativeproteins--Waters Corporation (NYSE:WAT) announced it is providing both technology and expertise to help advance plant-based protein science in collaboration...

Waters Corporation Schedules Second Quarter 2022 Earnings Conference Call

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will hold its Q2 2022 financial results conference call live on Tuesday, August 2nd 2022 at 8:00 a.m. eastern time. A live webcast of the p...

7 Stocks to Buy for a Summer Rally

These are seven great stocks to buy in anticipation for the start of an up move in share value in the coming weeks.

3 Stocks to Watch on Rising Demand for Scientific Instruments

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), Waters (WAT) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand, as...

Other symbols: BRKRMTD

Why Waters (WAT) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote Analytical Skills Development

SEOUL, South Korea--(BUSINESS WIRE)-- #bioanalysis--Waters Corporation announced a collaboration with BioInfra, a CRO based in South Korea, to jointly establish the ASEAN Academy for Bioanalysis.

4 Stocks With Upgraded Broker Ratings to Consider Right Now

One must follow rating upgrades by brokers as they have a deeper understanding of the stocks. We choose PBF Energy (PBF), Genuine Parts (GPC), RingCentral (RNG) and Waters (WAT) as these witness ratings...

Other symbols: GPCPBFRNG

Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development

MINNEAPOLIS--(BUSINESS WIRE)-- #ASMS2022--Waters Corporation unveiled new instruments, software and product enhancements at the American Society for Mass Spectrometry 2022 Annual Conference.

Why Is Waters (WAT) Down 6% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Waters Corporation Presentation at the Jefferies 2022 Global Health Care Conference

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2022 Global Healthcare Confer...

5 Stocks to Bet on Right Now on Upgraded Broker Ratings

One must follow rating upgrades by brokers as they have a deeper understanding of the stocks. We pick Genuine Parts (GPC), RingCentral (RNG) Waters (WAT), PBF Energy (PBF) and Arthur J.

Other symbols: AJGGPCPBFRNG

Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab

MILFORD, Mass. & NEWARK, Del.--(BUSINESS WIRE)---- $WAT #UDel--Waters Corporation opens Immerse Delaware, an innovation and research laboratory to address significant challenges in the biopharmaceutical...

Why Waters Corp Shares Are Surging Today

Waters Corp (NYSE: WAT) reported first-quarter FY22 revenue growth of 16% year-on-year in CC to $690.6 million, above the consensus of $632.8 million. Sales into the pharmaceutical market increased 19% ...

Waters (WAT) Q1 Earnings Surpass Estimates, Sales Rise Y/Y

Waters' (WAT) first-quarter results reflect gains from a strong momentum across pharmaceutical and industrial end-markets, and geographical regions.

Waters (WAT) Q1 Earnings and Revenues Beat Estimates

Waters (WAT) delivered earnings and revenue surprises of 20.69% and 9.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE: WAT) today announced its financial results for the first quarter of 2022. “Our teams continue to deliver excellent results despite the challeng...

Waters Corporation to Host Investor Day

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) announced today that it will host its 2022 Investor Day on Thursday, May 19, 2022, starting at 8:45 a.m. (ET) at the New York Stock Exchang...

Waters Corporation Q1 2022 Financial Results Webcast Invitation

MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (NYSE:WAT) will webcast its Q1 2022 financial results conference call live on Tuesday, May 3rd 2022 at 8:00 a.m. eastern time. A live webcast of the p...

Waters (WAT) Expands Portfolio With Xevo TQ Absolute System

Waters (WAT) unveils the Xevo TQ Absolute system, which is up to 15 times more sensitive, 45% smaller in size, and consumes up to 50% less electricity and gas supply.

Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer

MILFORD, Mass.--(BUSINESS WIRE)-- #bioanalysis--Waters introduces the Xevo TQ Absolute, the most sensitive and compact tandem quadrupole mass spectrometer in its class.

Here's Why Waters (WAT) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.